INTRODUCTION
============

In healthcare policy and research, summary measures regarding the burden of disease and injuries are needed for priority setting and rational allocation of limited resources (including budget).[@B1][@B2] In this context, during the 1990s, Alan D Lopez and Christopher J.L. Murray developed disability adjusted life year (DALY), an indicator that can comprehensively measure the health status of a population. DALY is the sum of years of life lost due to premature death (YLL) and years lost due to disability (YLD).[@B2] DALY is meaningful in that it expresses the health status of a population as a comprehensive quantitative indicator, rather than segmenting it by morbidity and mortality. It is being used as the representative indicator for measuring the global burden of disease in the Global Burden of Disease (GBD) study. In particular, the World Health Organization used YLD, a component of DALY, to estimate health-adjusted life expectancy (HALE), which is used as key evidence when prioritizing policies or allocating budget.

To combine YLL and YLD into the indicator of DALY, YLD must be estimated by the disability weight (DW). DW represents a measured value of specific health status and severity of the disease, with values ranging between 0 (perfect health) and 1 (equivalent to death). Therefore, DW acts as a bridge between disease morbidity and mortality.[@B3] In this context, DW of a specific disease must be set to accurately reflect the average characteristics of that disease. In other words, the relative severity of diseases must be well reflected in DW.

Research on DW has evolved along with the GBD study. In the 1990 GBD study, investigation using visual analogue scale (VAS) and person trade off (PTO) with 10 public health specialists produced DWs for 483 health conditions corresponding to 131 diseases and injuries.[@B4] Since 1996, several studies have been conducted to estimate DW in a variety of countries.[@B3][@B5][@B6][@B7][@B8] However, the methodology, validity, and universality of DW estimation are not adequately clear.[@B9][@B10] DWs used in the 2010 GBD study were estimated based on a household questionnaire and online surveys administered to 30,230 people in 5 countries (the United States, Peru, Tanzania, Bangladesh, and Indonesia). Paired comparison and population health equivalence (modified from a PTO) were used as valuation methodologies.[@B11] As an upgrade, the 2013 GBD study used DWs that reflected those from studies conducted in 4 European countries (the Netherlands, Sweden, Hungary, and Italy).[@B12] However, despite such attempts at a methodological upgrade, many scholars still question the validity of methodology for estimating DWs.[@B13][@B14][@B15] Nord[@B13] criticized that the agreement between countries for DWs used in the 2010 GBD study was exaggerated. The DW associated with each health condition is currently fixed across all social, cultural, and environmental contexts.[@B16]

In this context, there is an ongoing effort since 2000 to estimate DW that reflects the unique social and cultural context of Korea.[@B3][@B17][@B18][@B19] Most DW studies conducted in Korea have targeted people who received medical education to allow more objective and broader assessment of disease characteristics.[@B3][@B17][@B18] Although reflecting preferences of the general population is required for priority setting and rational allocation of limited resources, the general population may have biases about disease status and may not be able to determine the severity of the diseases that are not very well-known. Therefore, careful consideration of the target population for estimating DWs is important.

Moreover, the issue of the size of DW needs to be studied as well. Although a direct comparison may be difficult, the DWs used in the 2015 Korean National Burden of Disease (KNBD) study showed regular distribution around the value of 0.5 (normal distribution), whereas the DWs used in the GBD study were lower than those of the 2015 KNBD study. For example, Alzheimer disease and other dementias had DW of 0.069, 0.377, and 0.449 for mild, moderate, and severe cases in the GBD study,[@B12] respectively, whereas the DW used in the 2015 KNBD study had the value of 0.736.[@B18] Such a difference can significantly affect the size of YLD and even influence HALE.

The present study aimed to estimate cause-specific DWs based on the opinion of medical professional experts and discuss the differences found. Furthermore, the study also aimed to compare and assess the size of DW according to two analytical methods and estimate the most reasonable DW from the YLD and HALE estimation perspective. Accordingly, the study aimed to derive the Korean version DW update by estimating DWs according to the severity of major diseases.

METHODS
=======

Study design and participants
-----------------------------

A self-administered web-based survey was conducted based on the methodology of previous studies for estimating DWs.[@B3][@B18] The survey was performed from November 2018 to December 2018. In order to explore the possibility of expanding the participants in the survey, we included nurses and oriental medical doctors as well as physicians and medical students (third or fourth grade of a regular course). Participants were recruited through the promotion of the survey in the online community site for medical professionals and by word-of-mouth from other participants.

Valuation method and causes of disease
--------------------------------------

First, participants responded to their age group, sex, occupation, and specialty. Next, the participants assessed the severity of the causes of disease by using a ranking method. We used the complete ranking method listing five alternatives in view of the effectiveness and feasibility demonstrated in previous studies.[@B3][@B18][@B20] The participants ranked the five listed causes of disease in order of good health, considering the seriousness of the physical and mental problems caused by the diseases. The descriptions of the causes of disease were not presented to the participants and they judged the severity by looking at the names of the presented causes of disease.

A total of 313 causes of disease were used in this survey. The list of causes of disease utilized in this study is based on the GBD 2016 study.[@B21] In the GBD 2016 study, DALY and YLD were calculated for 333 and 328 causes of disease, respectively. After reviewing the list of the causes of disease from GBD 2016 study, 277 causes of disease were selected after considering duplication of causes of disease and the possibility of emerging causes of disease in Korea. Among the 277 causes of disease, 14 causes of diseases were subdivided by the degree of severity. For example, major depressive disorder was subdivided into 'major depressive disorder (mild),' 'major depressive disorder (moderate),' and 'major depressive disorder (severe).' In the case of diabetes mellitus, the severity was classified as the presence ('diabetes mellitus with complications') or absence of complications ('diabetes mellitus without complications'). Furthermore, 'allergic rhinitis,' 'atopic dermatitis,' and 'metabolic syndrome,' which were not included in the GBD 2016 study, were included in the list to calculate the magnitude of the problem in Korean National Burden of Disease study. 'Full health' and 'being dead' were also included in the list to identify participants who made illogical responses and to use them as anchor points in the analyses.

Participants conducted a total of 20 ranking methods to evaluate five alternatives. Among the 311 causes of disease (excluding 'full health' and 'being dead'), 5 randomly selected causes of disease were given to participants in each ranking method question. However, 'full health' was fixed as the first cause of disease in question 1 and the fifth cause of disease in question 11. Similarly, 'being dead' was fixed as the first cause of disease in question 5, fifth cause of disease in question 10, the first cause of disease in question 15, and the fifth cause of disease in question 20.

Analysis
--------

Descriptive analyses were performed to determine the socio-demographic characteristics of the participants. Before proceeding with the analyses of DWs, only the responses of participants who answered 'full health' in questions 1 and 11 with the best health state were included in the analyses. Then, the ranked data were converted into paired comparison data in accordance with previous studies.[@B3][@B18][@B20] For example, if the response of a participant was in the order of C1-C2-C3-C4-C5, it was converted to C1-C2, C1-C3, C1-C4, C1-C5, C2-C3, C2-C4, C2-C5, C3-C4, C3-C5, and C4-C5. Thus, paired comparison data were obtained by ranking method listing five alternatives. Probit regression analysis was conducted with these paired comparison data. The stated preference of the first cause of disease in the paired comparison was regarded as the dependent variable. The two causes of disease that were compared were considered as independent variables and 'being dead' was treated as a reference of the dummy variable. Using the coefficient estimates of the probit regression, the predicted probabilities of causes of disease were calculated.

In the process of rescaling predicted probability to DW on a scale from 0 to 1, two models were used. Model 1 was to rescale considering the normal distribution of DWs as in previous studies.[@B3][@B18] In Model 2, predicted probabilities taking the natural logarithm were rescaled considering the asymmetric distribution of DWs. 'Being dead (1)' and 'full health (0)' were used as anchor points in both Models. Subgroup analyses were also performed according to the occupation of participants. Group 1 comprised physicians and medical students as in the previous studies,[@B3][@B18] whereas Group 2 comprised nurses and oriental medical doctors. We determined the frequency distributions of the DWs from the models and calculated the Pearson correlation coefficients to compare the DWs from the models to those obtained in the most recent Korean DWs study.[@B18]

We used Stata 13.1 software (StataCorp, College Station, TX, USA) for all statistical analyses. In this study, *P* value less than 0.05 was regarded as statistically significant.

Ethics statement
----------------

This study was approved by the Institutional Review Board (IRB) of the Ulsan University Hospital (IRB No. 2018-11-034). All participants were informed about the purpose and process of the study and only those who agreed to participate joined this survey. Each participant received a 9,000 won coffee coupon.

RESULTS
=======

A total of 901 participants started the survey and 872 participants completed the survey. Among 872 participants, 66 participants were excluded from the analyses due to illogical responses such as 'full health' was not listed as the best health state. [Table 1](#T1){ref-type="table"} summarized the details of the socio-demographic characteristics of 806 participants used in the analyses. Most participants were in the 30s and about 70% were male. About two-thirds of the participants were specialists and there were more medical specialists than surgical specialists. Group 1 comprised only physicians and medical students and group 2 comprised only nurses and oriental medical doctors and included were 682 and 124 participants, respectively.

###### Characteristics of the study participants

![](jkms-35-e219-i001)

  Characteristics   Values, No. (%)            
  ----------------- -------------------------- ------------
  Age, yr                                      
                    19--29                     164 (20.3)
                    30--39                     621 (77.0)
                    ≤ 40                       21 (2.6)
  Sex                                          
                    Male                       561 (69.6)
                    Female                     245 (30.4)
  Occupation                                   
                    Medical student            12 (1.5)
                    General practitioner       76 (9.4)
                    Resident                   65 (8.1)
                    Specialist                 529 (65.6)
                    Nurse                      115 (14.3)
                    Oriental medical doctors   9 (1.1)
  Specialty                                    
                    Medical part               384 (47.6)
                    Surgical part              136 (16.9)
                    Others                     286 (35.5)
  Total             806 (100.0)                

[Table 2](#T2){ref-type="table"} shows the DWs by the model of analysis for each group. The mean of the DWs according to the models in each group was 0.490 (Model 1 in Group 1), 0.378 (Model 2 in Group 1), 0.506 (Model 1 in Group 2), and 0.459 (Model 2 in Group 2), respectively. In all analyses, 'Pancreatic cancer' had the highest DW as follows: 0.929 (Model 1 in Group 1), 0.724 (Model 2 in Group 1), 0.996 (Model 1 in Group 2), and 0.986 (Model 2 in Group 2). On the other hand, the cause of the disease with the lowest DW was acne vulgaris in Model 1 in Group 1 (0.059) and Model 2 in Group 1 (0.229). Cause of disease with the lowest DW differed according to the analysis method. Acne vulgaris, caries of deciduous teeth, and allergic rhinitis had low DWs overall.

###### Disability weights from each model for the subgroups
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  No.   Cause of disease                                                                Model 1 in Group 1   Model 2 in Group 1   Model 1 in Group 2   Model 2 in Group 2
  ----- ------------------------------------------------------------------------------- -------------------- -------------------- -------------------- --------------------
  1     Drug-susceptible tuberculosis                                                   0.385                0.318                0.522                0.444
  2     Multidrug-resistant tuberculosis without extensive drug resistance              0.651                0.434                0.632                0.504
  3     Extensively drug-resistant tuberculosis                                         0.682                0.453                0.672                0.529
  4     Latent tuberculosis infection                                                   0.218                0.268                0.212                0.324
  5     Drug-susceptible HIV/AIDS - tuberculosis                                        0.715                0.474                0.669                0.527
  6     Multidrug-resistant HIV/AIDS - tuberculosis without extensive drug resistance   0.784                0.529                0.850                0.688
  7     Extensively drug-resistant HIV/AIDS - tuberculosis                              0.783                0.527                0.803                0.636
  8     HIV/AIDS resulting in other diseases                                            0.756                0.505                0.791                0.624
  9     Diarrhoeal diseases                                                             0.179                0.258                0.246                0.335
  10    Typhoid fever                                                                   0.325                0.299                0.310                0.356
  11    Paratyphoid fever                                                               0.376                0.315                0.438                0.406
  12    Other intestinal infectious diseases                                            0.266                0.281                0.420                0.398
  13    Lower respiratory infections                                                    0.387                0.319                0.420                0.398
  14    Upper respiratory infections                                                    0.159                0.253                0.286                0.348
  15    Otitis media                                                                    0.169                0.256                0.137                0.302
  16    Pneumococcal meningitis                                                         0.606                0.410                0.518                0.442
  17    H influenzae type B meningitis                                                  0.613                0.413                0.551                0.458
  18    Meningococcal infection                                                         0.554                0.385                0.544                0.455
  19    Other meningitis                                                                0.583                0.398                0.651                0.516
  20    Encephalitis                                                                    0.693                0.460                0.673                0.529
  21    Diphtheria                                                                      0.348                0.306                0.468                0.418
  22    Whooping cough                                                                  0.339                0.303                0.279                0.346
  23    Tetanus                                                                         0.506                0.364                0.570                0.468
  24    Measles                                                                         0.321                0.298                0.320                0.360
  25    Varicella and herpes zoster                                                     0.262                0.280                0.403                0.391
  26    Malaria                                                                         0.420                0.331                0.467                0.418
  27    Chagas disease                                                                  0.575                0.394                0.604                0.487
  28    Visceral leishmaniasis                                                          0.424                0.332                0.520                0.443
  29    Cutaneous and mucocutaneous leishmaniasis                                       0.373                0.315                0.466                0.418
  30    African trypanosomiasis                                                         0.490                0.357                0.511                0.438
  31    Schistosomiasis                                                                 0.383                0.318                0.421                0.399
  32    Cysticercosis                                                                   0.417                0.329                0.558                0.462
  33    Cystic echinococcosis                                                           0.404                0.325                0.506                0.436
  34    Lymphatic filariasis                                                            0.492                0.358                0.588                0.478
  35    Onchocerciasis                                                                  0.275                0.284                0.429                0.402
  36    Trachoma                                                                        0.376                0.316                0.556                0.461
  37    Dengue                                                                          0.395                0.322                0.461                0.416
  38    Yellow fever                                                                    0.512                0.366                0.463                0.416
  39    Rabies                                                                          0.685                0.455                0.656                0.518
  40    Ascariasis                                                                      0.231                0.272                0.306                0.355
  41    Trichuriasis                                                                    0.332                0.301                0.377                0.381
  42    Hookworm disease                                                                0.222                0.269                0.330                0.363
  43    Food-borne trematodiases                                                        0.309                0.294                0.398                0.389
  44    Leprosy                                                                         0.602                0.408                0.692                0.543
  45    Ebola virus disease                                                             0.774                0.520                0.844                0.681
  46    Zika virus disease                                                              0.493                0.358                0.403                0.391
  47    Guinea worm disease                                                             0.349                0.307                0.451                0.411
  48    Other neglected tropical diseases                                               0.399                0.323                0.398                0.389
  49    Maternal haemorrhage                                                            0.599                0.406                0.374                0.380
  50    Maternal sepsis and other pregnancy related infections                          0.643                0.430                0.600                0.485
  51    Maternal hypertensive disorders                                                 0.410                0.327                0.416                0.396
  52    Maternal obstructed labour and uterine rupture                                  0.668                0.444                0.674                0.531
  53    Maternal abortion, miscarriage, and ectopic pregnancy                           0.379                0.316                0.219                0.326
  54    Other maternal disorders                                                        0.387                0.319                0.256                0.338
  55    Neonatal preterm birth complications                                            0.577                0.396                0.520                0.443
  56    Neonatal encephalopathy due to birth asphyxia and trauma                        0.815                0.558                0.785                0.618
  57    Neonatal sepsis and other neonatal infections                                   0.691                0.458                0.621                0.497
  58    Hemolytic disease and other neonatal jaundice                                   0.488                0.356                0.409                0.394
  59    Other neonatal disorders                                                        0.513                0.367                0.520                0.443
  60    Protein-energy malnutrition                                                     0.428                0.334                0.261                0.340
  61    Iodine deficiency                                                               0.210                0.266                0.325                0.362
  62    Vitamin A deficiency                                                            0.226                0.270                0.164                0.310
  63    Iron-deficiency anaemia                                                         0.179                0.258                0.210                0.323
  64    Other nutritional deficiencies                                                  0.239                0.274                0.184                0.316
  65    Syphilis                                                                        0.403                0.325                0.574                0.470
  66    Chlamydial infection                                                            0.344                0.305                0.335                0.365
  67    Gonococcal infection                                                            0.304                0.293                0.504                0.435
  68    Trichomoniasis                                                                  0.313                0.295                0.398                0.389
  69    Genital herpes                                                                  0.252                0.278                0.324                0.362
  70    Other sexually transmitted diseases                                             0.355                0.309                0.461                0.416
  71    Acute hepatitis A                                                               0.373                0.315                0.589                0.478
  72    Hepatitis B                                                                     0.393                0.321                0.273                0.344
  73    Hepatitis C                                                                     0.521                0.370                0.629                0.502
  74    Acute hepatitis E                                                               0.515                0.368                0.396                0.388
  75    Other infectious diseases                                                       0.249                0.277                0.219                0.326
  76    Lip and oral cavity cancer                                                      0.743                0.495                0.699                0.548
  77    Nasopharynx cancer                                                              0.847                0.594                0.741                0.580
  78    Other pharynx cancer                                                            0.777                0.523                0.669                0.527
  79    Oesophageal cancer                                                              0.870                0.623                0.808                0.641
  80    Stomach cancer (stage 1)                                                        0.440                0.338                0.535                0.450
  81    Stomach cancer (stage 2)                                                        0.617                0.416                0.570                0.468
  82    Stomach cancer (stage 3)                                                        0.796                0.540                0.913                0.779
  83    Stomach cancer (stage 4)                                                        0.914                0.694                0.963                0.883
  84    Colon and rectum cancers (stage 1)                                              0.476                0.352                0.587                0.477
  85    Colon and rectum cancers (stage 2)                                              0.650                0.434                0.786                0.619
  86    Colon and rectum cancers (stage 3)                                              0.807                0.550                0.873                0.718
  87    Colon and rectum cancers (stage 4)                                              0.868                0.620                0.941                0.831
  88    Liver cancer due to hepatitis B                                                 0.757                0.506                0.722                0.565
  89    Liver cancer due to hepatitis C                                                 0.757                0.506                0.712                0.558
  90    Liver cancer secondary to alcohol use (stage 1)                                 0.598                0.406                0.500                0.433
  91    Liver cancer secondary to alcohol use (stage 2)                                 0.700                0.465                0.811                0.644
  92    Liver cancer secondary to alcohol use (stage 3)                                 0.801                0.544                0.827                0.662
  93    Liver cancer secondary to alcohol use (stage 4)                                 0.927                0.719                0.963                0.882
  94    Liver cancer due to other causes                                                0.782                0.527                0.750                0.588
  95    Gallbladder and biliary tract cancer                                            0.816                0.559                0.702                0.550
  96    Pancreatic cancer                                                               0.929                0.724                0.996                0.986
  97    Larynx cancer                                                                   0.848                0.594                0.758                0.594
  98    Trachea, bronchus and lung cancers (stage 1)                                    0.556                0.385                0.710                0.556
  99    Trachea, bronchus and lung cancers (stage 2)                                    0.703                0.467                0.832                0.666
  100   Trachea, bronchus and lung cancers (stage 3)                                    0.876                0.631                0.851                0.689
  101   Trachea, bronchus and lung cancers (stage 4)                                    0.913                0.692                0.848                0.686
  102   Malignant skin melanoma                                                         0.807                0.550                0.784                0.618
  103   Non-melanoma skin cancer (squamous-cell carcinoma)                              0.645                0.431                0.566                0.466
  104   Non-melanoma skin cancer (basal-cell carcinoma)                                 0.675                0.449                0.716                0.560
  105   Breast cancer (stage 1)                                                         0.451                0.342                0.519                0.442
  106   Breast cancer (stage 2)                                                         0.572                0.393                0.650                0.515
  107   Breast cancer (stage 3)                                                         0.771                0.517                0.817                0.651
  108   Breast cancer (stage 4)                                                         0.851                0.598                0.905                0.766
  109   Cervical cancer (stage 1)                                                       0.433                0.335                0.627                0.501
  110   Cervical cancer (stage 2)                                                       0.567                0.390                0.572                0.469
  111   Cervical cancer (stage 3)                                                       0.715                0.474                0.783                0.617
  112   Cervical cancer (stage 4)                                                       0.869                0.621                0.956                0.866
  113   Uterine cancer                                                                  0.719                0.477                0.757                0.593
  114   Ovarian cancer                                                                  0.821                0.564                0.831                0.665
  115   Prostate cancer (stage 1)                                                       0.439                0.337                0.396                0.388
  116   Prostate cancer (stage 2)                                                       0.602                0.408                0.568                0.467
  117   Prostate cancer (stage 3)                                                       0.710                0.471                0.845                0.682
  118   Prostate cancer (stage 4)                                                       0.875                0.630                0.798                0.631
  119   Testicular cancer                                                               0.772                0.518                0.809                0.643
  120   Kidney cancer                                                                   0.771                0.517                0.796                0.629
  121   Bladder cancer                                                                  0.787                0.531                0.709                0.555
  122   Brain and nervous system cancer                                                 0.882                0.640                0.802                0.635
  123   Thyroid cancer (stage 1)                                                        0.257                0.279                0.474                0.421
  124   Thyroid cancer (stage 2)                                                        0.472                0.350                0.556                0.461
  125   Thyroid cancer (stage 3)                                                        0.624                0.419                0.688                0.540
  126   Thyroid cancer (stage 4)                                                        0.805                0.549                0.926                0.802
  127   Mesothelioma                                                                    0.766                0.513                0.639                0.508
  128   Hodgkin lymphoma                                                                0.719                0.477                0.749                0.587
  129   Non-Hodgkin\'s lymphoma                                                         0.722                0.479                0.616                0.494
  130   Multiple myeloma                                                                0.718                0.477                0.677                0.532
  131   Acute lymphoid leukaemia                                                        0.827                0.570                0.785                0.618
  132   Chronic lymphoid leukaemia                                                      0.752                0.502                0.770                0.605
  133   Acute myeloid leukaemia                                                         0.830                0.573                0.822                0.656
  134   Chronic myeloid leukaemia                                                       0.764                0.512                0.843                0.679
  135   Other leukaemia                                                                 0.823                0.566                0.863                0.705
  136   Other neoplasms                                                                 0.574                0.394                0.540                0.453
  137   Rheumatic heart disease                                                         0.634                0.424                0.721                0.565
  138   Ischaemic heart disease                                                         0.703                0.466                0.728                0.570
  139   Ischemic stroke (mild)                                                          0.560                0.387                0.454                0.412
  140   Ischemic stroke (moderate)                                                      0.797                0.541                0.793                0.626
  141   Ischemic stroke (severe)                                                        0.843                0.588                0.716                0.560
  142   Hemorrhagic stroke                                                              0.800                0.543                0.856                0.696
  143   Hypertensive heart disease                                                      0.474                0.351                0.646                0.512
  144   Myocarditis                                                                     0.663                0.441                0.550                0.458
  145   Alcoholic cardiomyopathy                                                        0.649                0.433                0.674                0.531
  146   Other cardiomyopathy                                                            0.714                0.474                0.612                0.492
  147   Atrial fibrillation and flutter                                                 0.549                0.382                0.711                0.556
  148   Peripheral vascular disease                                                     0.449                0.341                0.407                0.393
  149   Endocarditis                                                                    0.690                0.458                0.603                0.487
  150   Other cardiovascular and circulatory diseases                                   0.562                0.388                0.511                0.438
  151   Chronic obstructive pulmonary disease (mild)                                    0.474                0.351                0.617                0.494
  152   Chronic obstructive pulmonary disease (moderate)                                0.658                0.438                0.577                0.472
  153   Chronic obstructive pulmonary disease (severe)                                  0.753                0.503                0.812                0.646
  154   Silicosis                                                                       0.666                0.443                0.624                0.499
  155   Asbestosis                                                                      0.653                0.436                0.656                0.519
  156   Coal workers pneumoconiosis                                                     0.658                0.438                0.745                0.584
  157   Other pneumoconiosis                                                            0.582                0.398                0.669                0.527
  158   Asthma                                                                          0.409                0.327                0.330                0.364
  159   Interstitial lung disease and pulmonary sarcoidosis                             0.712                0.473                0.803                0.637
  160   Other chronic respiratory diseases                                              0.492                0.358                0.532                0.449
  161   Cirrhosis and other chronic liver diseases due to hepatitis B                   0.665                0.443                0.588                0.478
  162   Cirrhosis and other chronic liver diseases due to hepatitis C                   0.676                0.449                0.662                0.522
  163   Cirrhosis and other chronic liver diseases due to alcohol use (mild)            0.519                0.369                0.518                0.442
  164   Cirrhosis and other chronic liver diseases due to alcohol use (moderate)        0.633                0.424                0.682                0.536
  165   Cirrhosis and other chronic liver diseases due to alcohol use (severe)          0.679                0.451                0.551                0.458
  166   Cirrhosis and other chronic liver diseases due to other causes                  0.628                0.421                0.517                0.441
  167   Peptic ulcer disease                                                            0.238                0.274                0.319                0.360
  168   Gastritis and duodenitis                                                        0.161                0.254                0.131                0.300
  169   Appendicitis                                                                    0.225                0.270                0.317                0.359
  170   Paralytic ileus and intestinal obstruction                                      0.466                0.347                0.699                0.548
  171   Inguinal, femoral, and abdominal hernia                                         0.261                0.280                0.454                0.413
  172   Inflammatory bowel disease                                                      0.449                0.341                0.360                0.375
  173   Vascular intestinal disorders                                                   0.499                0.361                0.498                0.432
  174   Gallbladder and biliary diseases                                                0.429                0.334                0.307                0.355
  175   Pancreatitis                                                                    0.456                0.344                0.537                0.451
  176   Other digestive diseases                                                        0.158                0.253                0.178                0.314
  177   Alzheimer\'s disease and other dementias                                        0.660                0.440                0.724                0.566
  178   Parkinson\'s disease                                                            0.697                0.462                0.566                0.466
  179   Epilepsy                                                                        0.612                0.413                0.730                0.571
  180   Multiple sclerosis                                                              0.665                0.442                0.621                0.497
  181   Motor neuron disease                                                            0.701                0.465                0.571                0.468
  182   Migraine                                                                        0.189                0.261                0.197                0.320
  183   Tension-type headache                                                           0.176                0.257                0.198                0.320
  184   Other neurological disorders                                                    0.495                0.359                0.303                0.354
  185   Schizophrenia                                                                   0.698                0.463                0.735                0.575
  186   Alcohol use disorders                                                           0.391                0.321                0.326                0.362
  187   Opioid use disorders                                                            0.504                0.363                0.528                0.446
  188   Cocaine use disorders                                                           0.490                0.357                0.416                0.396
  189   Amphetamine use disorders                                                       0.518                0.369                0.646                0.512
  190   Cannabis use disorders                                                          0.397                0.322                0.519                0.442
  191   Other drug use disorders                                                        0.299                0.291                0.289                0.349
  192   Major depressive disorder (mild)                                                0.369                0.313                0.417                0.397
  193   Major depressive disorder (moderate)                                            0.554                0.385                0.509                0.437
  194   Major depressive disorder (severe)                                              0.570                0.392                0.668                0.527
  195   Dysthymia                                                                       0.229                0.271                0.243                0.334
  196   Bipolar disorder                                                                0.499                0.361                0.536                0.450
  197   Anxiety disorders                                                               0.308                0.294                0.317                0.359
  198   Anorexia nervosa                                                                0.361                0.311                0.249                0.336
  199   Bulimia nervosa                                                                 0.337                0.303                0.353                0.372
  200   Autism                                                                          0.537                0.377                0.490                0.429
  201   Asperger syndrome and other autistic spectrum disorders                         0.505                0.363                0.560                0.463
  202   Attention-deficit/hyperactivity disorder                                        0.193                0.262                0.258                0.339
  203   Conduct disorder                                                                0.314                0.296                0.323                0.361
  204   Idiopathic developmental intellectual disability                                0.469                0.349                0.524                0.445
  205   Other mental and substance use disorders                                        0.423                0.332                0.428                0.402
  206   Diabetes mellitus without complications                                         0.324                0.299                0.332                0.364
  207   Diabetes mellitus with complications                                            0.534                0.376                0.745                0.584
  208   Acute glomerulonephritis                                                        0.498                0.360                0.446                0.409
  209   Chronic kidney disease due to diabetes mellitus                                 0.699                0.464                0.665                0.524
  210   Chronic kidney disease due to hypertension                                      0.604                0.409                0.570                0.468
  211   Chronic kidney disease due to glomerulonephritis                                0.652                0.435                0.587                0.477
  212   Chronic kidney disease due to other causes                                      0.617                0.415                0.591                0.479
  213   Interstitial nephritis and urinary tract infections                             0.420                0.331                0.634                0.505
  214   Urolithiasis                                                                    0.266                0.282                0.480                0.424
  215   Benign prostatic hyperplasia                                                    0.232                0.272                0.258                0.339
  216   Male infertility                                                                0.262                0.281                0.320                0.360
  217   Other urinary diseases                                                          0.195                0.262                0.209                0.323
  218   Uterine fibroids                                                                0.214                0.267                0.243                0.334
  219   Polycystic ovarian syndrome                                                     0.374                0.315                0.223                0.328
  220   Female infertility                                                              0.313                0.295                0.341                0.367
  221   Endometriosis                                                                   0.330                0.301                0.344                0.369
  222   Genital prolapse                                                                0.390                0.320                0.495                0.431
  223   Premenstrual syndrome                                                           0.128                0.246                0.103                0.292
  224   Other gynecological diseases                                                    0.243                0.275                0.281                0.346
  225   Thalassemias                                                                    0.449                0.341                0.411                0.395
  226   Thalassaemias trait                                                             0.459                0.345                0.470                0.420
  227   Sickle cell disorders                                                           0.517                0.368                0.589                0.478
  228   Sickle cell trait                                                               0.495                0.359                0.533                0.449
  229   G6PD deficiency                                                                 0.536                0.376                0.586                0.477
  230   G6PD trait                                                                      0.536                0.377                0.577                0.472
  231   Other hemoglobinopathies and hemolytic anaemias                                 0.484                0.355                0.543                0.454
  232   Endocrine, metabolic, blood, and immune disorders                               0.451                0.342                0.488                0.427
  233   Rheumatoid arthritis                                                            0.425                0.332                0.422                0.399
  234   Osteoarthritis (mild)                                                           0.257                0.279                0.303                0.354
  235   Osteoarthritis (moderate)                                                       0.394                0.322                0.440                0.407
  236   Osteoarthritis (severe)                                                         0.494                0.359                0.549                0.457
  237   Low back pain (mild)                                                            0.119                0.243                0.051                0.278
  238   Low back pain (moderate)                                                        0.275                0.284                0.368                0.378
  239   Low back pain (severe)                                                          0.344                0.305                0.296                0.352
  240   Neck pain                                                                       0.126                0.245                0.154                0.307
  241   Gout                                                                            0.332                0.301                0.405                0.392
  242   Other musculoskeletal disorders                                                 0.218                0.268                0.207                0.322
  243   Neural tube defects                                                             0.749                0.499                0.700                0.549
  244   Congenital heart anomalies                                                      0.682                0.453                0.670                0.528
  245   Orofacial clefts                                                                0.528                0.373                0.605                0.488
  246   Down\'s syndrome                                                                0.639                0.427                0.457                0.414
  247   Turner syndrome                                                                 0.551                0.383                0.449                0.410
  248   Klinefelter syndrome                                                            0.572                0.393                0.617                0.495
  249   Other chromosomal abnormalities                                                 0.655                0.437                0.550                0.458
  250   Congenital musculoskeletal and limb anomalies                                   0.651                0.434                0.573                0.470
  251   Urogenital congenital anomalies                                                 0.530                0.374                0.539                0.452
  252   Digestive congenital anomalies                                                  0.533                0.375                0.552                0.459
  253   Other congenital anomalies                                                      0.582                0.398                0.488                0.428
  254   Eczema                                                                          0.145                0.250                0.128                0.299
  255   Psoriasis                                                                       0.231                0.272                0.064                0.282
  256   Cellulitis                                                                      0.250                0.277                0.362                0.375
  257   Pyoderma                                                                        0.369                0.313                0.355                0.373
  258   Scabies                                                                         0.197                0.263                0.290                0.349
  259   Fungal skin diseases                                                            0.210                0.266                0.179                0.314
  260   Viral skin diseases                                                             0.217                0.268                0.297                0.352
  261   Acne vulgaris                                                                   0.059                0.229                \-                   \-
  262   Alopecia areata                                                                 0.125                0.245                0.123                0.298
  263   Pruritus                                                                        0.104                0.240                0.018                0.270
  264   Urticaria                                                                       0.098                0.238                0.142                0.303
  265   Decubitus ulcer                                                                 0.488                0.356                0.390                0.386
  266   Other skin and subcutaneous diseases                                            0.135                0.247                0.145                0.304
  267   Glaucoma                                                                        0.375                0.315                0.274                0.344
  268   Cataract                                                                        0.244                0.275                0.237                0.332
  269   Macular degeneration                                                            0.431                0.334                0.465                0.417
  270   Refraction and accommodation disorders                                          0.222                0.269                0.255                0.338
  271   Age-related and other hearing loss                                              0.251                0.277                0.213                0.325
  272   Other vision loss                                                               0.625                0.420                0.468                0.419
  273   Other sense organ diseases                                                      0.327                0.300                0.445                0.409
  274   Caries of deciduous teeth                                                       0.062                0.230                0.053                0.279
  275   Caries of permanent teeth                                                       0.125                0.245                0.076                0.285
  276   Periodontal disease                                                             0.211                0.266                0.212                0.324
  277   Edentulism and severe tooth loss                                                0.434                0.335                0.525                0.445
  278   Other oral disorders                                                            0.207                0.265                0.260                0.339
  279   Pedestrian road injuries                                                        0.425                0.332                0.389                0.386
  280   Cyclist road injuries                                                           0.280                0.286                0.223                0.328
  281   Motorcyclist road injuries                                                      0.546                0.381                0.492                0.429
  282   Motor vehicle road injuries                                                     0.492                0.358                0.321                0.360
  283   Other road injuries                                                             0.333                0.302                0.462                0.416
  284   Other transport injuries                                                        0.389                0.320                0.454                0.413
  285   Falls                                                                           0.521                0.370                0.555                0.460
  286   Drowning                                                                        0.527                0.372                0.414                0.396
  287   Fire, heat, and hot substances                                                  0.373                0.314                0.350                0.371
  288   Poisonings                                                                      0.508                0.365                0.527                0.446
  289   Unintentional firearm injuries                                                  0.468                0.348                0.485                0.426
  290   Unintentional suffocation                                                       0.677                0.450                0.773                0.608
  291   Other exposure to mechanical forces                                             0.298                0.291                0.304                0.354
  292   Adverse effects of medical treatment                                            0.305                0.293                0.412                0.395
  293   Venomous animal contact                                                         0.390                0.320                0.458                0.414
  294   Non-venomous animal contact                                                     0.135                0.247                0.185                0.316
  295   Pulmonary aspiration and foreign body in airway                                 0.578                0.396                0.557                0.461
  296   Foreign body in eyes                                                            0.125                0.245                0.086                0.288
  297   Foreign body in other body part                                                 0.154                0.252                0.256                0.338
  298   Environmental heat and cold exposure                                            0.254                0.278                0.292                0.350
  299   Other unintentional injuries                                                    0.230                0.272                0.282                0.347
  300   Self-harm by firearm                                                            0.563                0.389                0.657                0.519
  301   Self-harm by other specified means                                              0.561                0.388                0.541                0.453
  302   Assault by firearm                                                              0.509                0.365                0.411                0.395
  303   Assault by sharp object                                                         0.226                0.270                0.258                0.339
  304   Sexual violence                                                                 0.503                0.362                0.594                0.481
  305   Assault by other means                                                          0.238                0.274                0.365                0.376
  306   Exposure to forces of nature                                                    0.244                0.275                0.339                0.367
  307   Conflict and terrorism                                                          0.500                0.361                0.520                0.443
  308   Executions and police conflict                                                  0.671                0.446                0.760                0.596
  309   Allergic rhinitis                                                               0.082                0.235                0.111                0.294
  310   Atopic dermatitis                                                               0.227                0.271                0.159                0.308
  311   Metabolic syndrome                                                              0.271                0.283                0.232                0.330
  \-    Mean                                                                            0.490                0.378                0.506                0.459

HIV/AIDS = Human immunodeficiency virus infection and acquired immune deficiency syndrome.

The DWs of causes of disease that were classified by severity are shown in [Table 3](#T3){ref-type="table"}. Furthermore, [Table 3](#T3){ref-type="table"} also shows the DWs calculated from a previous study for comparison.[@B3] In the results of Group 1, there was no case where the DWs were reversed according to severity. However, in Group 2, there were some cases in which DWs were reversed according to severity. For example, among the results of 'Model 2 in Group 2,' the DW of 'Ischemic stroke (moderate)' was 0.626, but that of 'Ischemic stroke (severe)' was 0.560. In addition, the results of Model 2 showed that the DWs were generally low in causes of disease with high severity, compared with those from a previous study. For example, in the case of 'trachea, bronchus, and lung cancers (stage 4),' the DW of the previous study was 0.906, but that of 'Model 2 in Group 1' was estimated to be 0.692.

###### Comparison of disability weights among causes of disease subdivided by severity

![](jkms-35-e219-i003)

  No.   Cause of disease                                                           Model 1 in Group 1   Model 2 in Group 1   Model 1 in Group 2   Model 2 in Group 2   A previous study
  ----- -------------------------------------------------------------------------- -------------------- -------------------- -------------------- -------------------- ------------------
  80    Stomach cancer (stage 1)                                                   0.440                0.338                0.535                0.450                0.462
  81    Stomach cancer (stage 2)                                                   0.617                0.416                0.570                0.468                0.669
  82    Stomach cancer (stage 3)                                                   0.796                0.540                0.913                0.779                0.823
  83    Stomach cancer (stage 4)                                                   0.914                0.694                0.963                0.883                0.880
  84    Colon and rectum cancers (stage 1)                                         0.476                0.352                0.587                0.477                0.496
  85    Colon and rectum cancers (stage 2)                                         0.650                0.434                0.786                0.619                0.689
  86    Colon and rectum cancers (stage 3)                                         0.807                0.550                0.873                0.718                0.841
  87    Colon and rectum cancers (stage 4)                                         0.868                0.620                0.941                0.831                0.870
  90    Liver cancer secondary to alcohol use (stage 1)                            0.598                0.406                0.500                0.433                0.603
  91    Liver cancer secondary to alcohol use (stage 2)                            0.700                0.465                0.811                0.644                0.718
  92    Liver cancer secondary to alcohol use (stage 3)                            0.801                0.544                0.827                0.662                0.785
  93    Liver cancer secondary to alcohol use (stage 4)                            0.927                0.719                0.963                0.882                0.876
  98    Trachea, bronchus and lung cancers (stage 1)                               0.556                0.385                0.710                0.556                0.600
  99    Trachea, bronchus and lung cancers (stage 2)                               0.703                0.467                0.832                0.666                0.738
  100   Trachea, bronchus and lung cancers (stage 3)                               0.876                0.631                0.851                0.689                0.758
  101   Trachea, bronchus and lung cancers (stage 4)                               0.913                0.692                0.848                0.686                0.906
  105   Breast cancer (stage 1)                                                    0.451                0.342                0.519                0.442                0.439
  106   Breast cancer (stage 2)                                                    0.572                0.393                0.650                0.515                0.597
  107   Breast cancer (stage 3)                                                    0.771                0.517                0.817                0.651                0.724
  108   Breast cancer (stage 4)                                                    0.851                0.598                0.905                0.766                0.864
  109   Cervical cancer (stage 1)                                                  0.433                0.335                0.627                0.501                0.431
  110   Cervical cancer (stage 2)                                                  0.567                0.390                0.572                0.469                0.553
  111   Cervical cancer (stage 3)                                                  0.715                0.474                0.783                0.617                0.813
  112   Cervical cancer (stage 4)                                                  0.869                0.621                0.956                0.866                0.855
  115   Prostate cancer (stage 1)                                                  0.439                0.337                0.396                0.388                0.458
  116   Prostate cancer (stage 2)                                                  0.602                0.408                0.568                0.467                0.613
  117   Prostate cancer (stage 3)                                                  0.710                0.471                0.845                0.682                0.742
  118   Prostate cancer (stage 4)                                                  0.875                0.630                0.798                0.631                0.838
  123   Thyroid cancer (stage 1)                                                   0.257                0.279                0.474                0.421                0.301
  124   Thyroid cancer (stage 2)                                                   0.472                0.350                0.556                0.461                0.484
  125   Thyroid cancer (stage 3)                                                   0.624                0.419                0.688                0.540                0.639
  126   Thyroid cancer (stage 4)                                                   0.805                0.549                0.926                0.802                0.779
  139   Ischemic stroke (mild)                                                     0.560                0.387                0.454                0.412                0.540
  140   Ischemic stroke (moderate)                                                 0.797                0.541                0.793                0.626                0.787
  141   Ischemic stroke (severe)                                                   0.843                0.588                0.716                0.560                0.840
  151   Chronic obstructive pulmonary disease (mild)                               0.474                0.351                0.617                0.494                0.408
  152   Chronic obstructive pulmonary disease (moderate)                           0.658                0.438                0.577                0.472                0.703
  153   Chronic obstructive pulmonary disease (severe)                             0.753                0.503                0.812                0.646                0.722
  163   Cirrhosis and other chronic liver diseases due to alcohol use (mild)       0.519                0.369                0.518                0.442                0.484
  164   Cirrhosis and other chronic liver diseases due to alcohol use (moderate)   0.633                0.424                0.682                0.536                0.668
  165   Cirrhosis and other chronic liver diseases due to alcohol use (severe)     0.679                0.451                0.551                0.458                0.717
  192   Major depressive disorder (mild)                                           0.369                0.313                0.417                0.397                0.279
  193   Major depressive disorder (moderate)                                       0.554                0.385                0.509                0.437                0.528
  194   Major depressive disorder (severe)                                         0.570                0.392                0.668                0.527                0.569
  206   Diabetes mellitus without complications                                    0.324                0.299                0.332                0.364                0.334
  207   Diabetes mellitus with complications                                       0.534                0.376                0.745                0.584                0.663
  234   Osteoarthritis (mild)                                                      0.257                0.279                0.303                0.354                0.216
  235   Osteoarthritis (moderate)                                                  0.394                0.322                0.440                0.407                0.415
  236   Osteoarthritis (severe)                                                    0.494                0.359                0.549                0.457                0.575
  237   Low back pain (mild)                                                       0.119                0.243                0.051                0.278                0.138
  238   Low back pain (moderate)                                                   0.275                0.284                0.368                0.378                0.310
  239   Low back pain (severe)                                                     0.344                0.305                0.296                0.352                0.456

[Fig. 1](#F1){ref-type="fig"} shows the distributions of DWs in all analyzes. The distributions of DWs for 'Model 1 in Group 1' and 'Model 1 in Group 2' were close to normal distribution. However, the distributions of DWs for 'Model 2 in Group 1' and 'Model 2 in Group 2' were right skewed. About two-thirds of the causes of disease had DWs of 0.2 to 0.4 in 'Model 2 in Group 1.' Furthermore, in 'Model 2 in Group 1,' there was no cause of disease with a DW of more than 0.8 or less than 0.2.

![Distribution of disability weights in each analytical method.](jkms-35-e219-g001){#F1}

The correlations between the DWs for 200 overlapping causes of disease from a previous study[@B18] and this study are shown in [Fig. 2](#F2){ref-type="fig"}. The Pearson correlation coefficient was highest in 'Model 1 in Group 1 (0.975)' and lowest in 'Model 2 in Group 2 (0.867).' When the DWs of Model 1 in Group 1 were compared with those of the previous study, a total of 96 causes of disease had decreased DW, but 104 causes had increased DW ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). However, when the DWs of 'Model 2 in Group 1' were compared to the previous study, a total of 155 causes had decreased the DW, but 45 causes had increased DW. In particular, the DW of the 'Cervical cancer (stage 3)' in 'Model 2 in Group 1 (0.474)' decreased by 0.338 compared to the previous study (0.813). However, the DW of 'Falls' in 'Model 2 in Group 1 (0.370)' increased by 0.205 compared to the previous study (0.165).

![Correlation of disability weights between a previous study and this study.\
^a^Data from the most recent Korean disability weights study.[@B18]](jkms-35-e219-g002){#F2}

DISCUSSION
==========

In this study, we updated the methodology to obtain reasonable DWs for the calculation of DALY and HALE. Specifically, we attempted to determine whether DWs could be calculated for physicians and medical students as well as nurses and oriental medical doctors. In addition, we attempted to identify an optimal model for calculating valid DWs through evaluating the size and distribution of DWs as well as correlation with previous research results and reversal of DW according to the severity of diseases. The survey method and the analytical model for the calculation of DWs, which have been proved through this study, can be used in the calculation of the DW in other countries.

Above all, it is significant because a large number of medical professionals participated in this DW study. Most of the studies on DW conducted for medical professionals were performed by dozens of participants.[@B22] A total of 901 medical professionals participated in the survey and responses of 806 medical professionals were utilized in the analyses. The number of participants was higher than that in the most recent DW study in Korea involving 605 physicians and medical students. Although healthcare professionals have a wealth of knowledge about a variety of health conditions and diseases and can objectively compare and evaluate diseases, questions can arise as to whether they can objectively compare and evaluate diseases as the area of expertise of healthcare professionals becomes increasingly fragmented.[@B23] This limitation may be overcome by more healthcare professionals with diverse specializations participating in DW survey.

In this study, we included nurses and oriental medical doctors as participants of this study. A total of 115 nurses and 9 oriental medical doctors participated in the survey and the results of these responses were analyzed in Group 2. In Group 2, there were some cases in which DWs were reversed according to severity, while there was no case where the DWs were reversed according to the severity in Group 1. Nurses and oriental medical doctors who participated in this study were still unfamiliar with the DW study and seem to have an inconsistent response. In previous studies, healthcare professionals or medical experts have been used extensively in DW studies, but few have specifically identified who will be healthcare professionals or medical experts.[@B22][@B23] Based on the results of this study, it is difficult to make a quick judgment on whether nurses or oriental medicine doctors are not worthy of participating in DW study. However, careful attention should be paid to including medical professionals unconditionally in DW survey, simply because they have medical qualifications. In the DW study, it will be important to educate participants to understand the significance of DW and to make a consistent assessment of the disease during the survey.[@B24]

In this study, we attempted to revise the analysis method to obtain valid DWs. The DWs estimated in the previous KNBD studies showed normal distribution,[@B3][@B18] whereas the DWs calculated in the GBD studies showed right-skewed distribution. Accordingly, the estimated DWs in KNBD studies were somewhat higher than those in the GBD study. For example, the DWs for 'anorexia nervosa' and 'bulimia nervosa' were 0.224 and 0.223 in the GBD 2013 study,[@B12] respectively, but 0.420 and 0.392 in the most recent KNBD study,[@B18] respectively. In fact, it is not easy to assess which DWs are valid, but such difference can significantly affect the size of YLD and even influence HALE in KNBD studies. Therefore, this study attempted to revise the method of calculating the DWs considering the distribution assumption of the DWs in the GBD study. In other words, we compared the results of the analytical model assuming a normal distribution of DWs (Model 1) and the results of an analytical model assuming a right-skewed distribution of DWs (Model 2).

As a result, it was confirmed that the DWs in Model 2 was estimated to be smaller than those in Model 1. For example, the DW of 'Pancreatic cancer' was 0.929 in Model 1 (Group 1), but 0.724 in Model 2 (Group 1). In Model 2 (Group 1), however, most of the DWs were distributed between 0.2 and 0.4, and there was no cause of disease with DWs of more than 0.8 or less than 0.2. For example, the DW of 'Otitis media' was 0.169 in Model 1 (Group 1) but 0.256 in Model 2 (Group 1). It was confirmed that the variance of the DWs between causes of disease estimated in Model 2 was smaller than that of Model 1. Therefore, efforts should continue to be made to produce valid disability weights that can increase the discrimination between causes of disease while meeting distribution assumptions. It is necessary to try to have multiple anchor points and to give constant values using data from health-related quality of life.

Assessing the validity of DWs is not an easy task.[@B22][@B24] This is because there is no gold standard for DWs, and we estimate DWs for hundreds of causes of disease at once. Therefore, in this study, various methods were used to evaluate the validity of DWs. We examined whether there was a reversal in DWs of causes of disease with other severity levels and we also checked the distribution of DWs and compared them with previous results. Although not used in this study, it is also possible to compare EQ-5D\'s DWs with utility weights.[@B19][@B25] Considering these points together, we conclude that 'Model 2 in Group 1' has several advantages over others. However, due to the emergence of new diseases, changes in characteristics of the disease, development of new drugs and treatment techniques, and changes in social perspectives on disability, the DWs calculated in the past may not be valid presently, so that it is necessary to evaluate and revise DWs continuously.

One limitation of this study is that the number of participating nurses or oriental medical doctors was relatively small compared to physicians. Although the number of participants does not seem to be small compared to other studies, the participation of more people in the DW survey can help to reasonably estimate the DWs of a variety of causes of disease. Future studies should include a higher number of nurses and oriental medical doctors for examining the possibility of calculating the DW.

In conclusion, we attempted to calculate DWs by surveying various types of medical professionals using the previous analysis methods as well as the revised analysis method. Finally, we estimated DWs for a total of 313 causes of disease for the KNBD study. The DWs from this study can be used to estimate accurate DALY and health life expectancy, such as HALE, in Korea.
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[^1]: ^\*^Young-Eun Kim and Min-Woo Jo contributed equally to this work.
